<SEC-DOCUMENT>0001903596-25-000277.txt : 20250520
<SEC-HEADER>0001903596-25-000277.hdr.sgml : 20250520
<ACCEPTANCE-DATETIME>20250520150418
ACCESSION NUMBER:		0001903596-25-000277
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250520
DATE AS OF CHANGE:		20250520

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-60249
		FILM NUMBER:		25968153

	BUSINESS ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
		BUSINESS PHONE:		(561) 426-4444

	MAIL ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Silvercape Investments Ltd
		CENTRAL INDEX KEY:			0002059711
		ORGANIZATION NAME:           	
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D

	BUSINESS ADDRESS:	
		STREET 1:		80 ROBINSON ROAD, #13-03
		CITY:			SINGAPORE
		STATE:			U0
		ZIP:			068898
		BUSINESS PHONE:		6597256448

	MAIL ADDRESS:	
		STREET 1:		FOURTH FLOOR, ONE CAPITAL PLACE
		STREET 2:		P.O. BOX 847
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1103
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Silvercape Investments Ltd -->
          <cik>0002059711</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, $.001 Par Value</securitiesClassTitle>
      <dateOfEvent>05/18/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001040130</issuerCIK>
        <issuerCUSIP>716382106</issuerCUSIP>
        <issuerName>PETMED EXPRESS, INC.</issuerName>
        <address>
          <com:street1>700 NW 1st Avenue</com:street1>
          <com:street2>Suite 1200</com:street2>
          <com:city>Miami</com:city>
          <com:stateOrCountry>FL</com:stateOrCountry>
          <com:zipCode>33136</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Carlos A. Mas</personName>
          <personPhoneNum>(305) 530-0050</personPhoneNum>
          <personAddress>
            <com:street1>700 NW 1st Avenue, Suite 1200</com:street1>
            <com:city>Miami</com:city>
            <com:stateOrCountry>FL</com:stateOrCountry>
            <com:zipCode>33136</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0002059711</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>SilverCape Investments Limited</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>2300318.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>2300318.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>2300318.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>11.1</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>Based on 20,656,457 shares of Common Stock outstanding as of February 10, 2025, as last reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Peter Kennedy</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2300318.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2300318.00</sharedDispositivePower>
        <aggregateAmountOwned>2300318.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>11.1</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>* Peter Kennedy, the managing director of SilverCape Investments Limited ("SilverCape"), has voting and investment power with respect to the Common Stock held by SilverCape. Mr. Kennedy disclaims any beneficial ownership of the Common Stock beneficially owned by SilverCape.
** Based on 20,656,457 shares of Common Stock outstanding as of February 10, 2025, as last reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, $.001 Par Value</securityTitle>
        <issuerName>PETMED EXPRESS, INC.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>700 NW 1st Avenue</com:street1>
          <com:street2>Suite 1200</com:street2>
          <com:city>Miami</com:city>
          <com:stateOrCountry>FL</com:stateOrCountry>
          <com:zipCode>33136</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>This statement relates to shares of common stock, par value $.001 per share (the "Common Stock"), of Petmed Express, Inc., a Florida corporation (the "Issuer").  The address of the principal executive office of the Issuer is 420 South Congress Avenue, Delray Beach, Florida 33445.</commentText>
      </item1>
      <item2>
        <filingPersonName>This Schedule 13D is being filed jointly by SilverCape Investments Limited ("SilverCape")  and Peter Kennedy ("Kennedy"). The foregoing persons are hereinafter sometimes referred to collectively as the "Reporting Persons."</filingPersonName>
        <principalBusinessAddress>The principal business address of the Reporting Persons is c/o Trident Trust Company (Cayman) Limited, Fourth Floor, One Capital Place, P.O. Box 847, George Town, Grand Cayman KY1-1103, Cayman Islands.</principalBusinessAddress>
        <principalJob>The principal business of SilverCape is to be an investment company. The principal business of Kennedy is to serve as the Managing Director of SilverCape.</principalJob>
        <hasBeenConvicted>During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which any of the Reporting Persons was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>SilverCape is organized under the laws of the Cayman Islands. Mr. Kennedy is a citizen of the United States.</citizenship>
      </item2>
      <item3>
        <fundsSource>The Reporting Persons purchased the shares of Common Stock covered by this Schedule 13D in open market purchases for an aggregate purchase price of $10,332,118. The source of the Reporting Persons' payment of the purchase price for each purchase of shares of Common Stock covered by this Schedule 13D was working capital of SilverCape.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>The Reporting Persons have been an investor in the Issuer since February 2025 and hold the Common Stock for investment purposes. The Reporting Persons have previously reported their beneficial ownership of the Issuer's securities in a statement on Schedule 13G filed on March 10, 2025, as amended on March 27, 2025. The Reporting Persons intend to engage in discussions with the management of the Issuer and/or the Issuer's board of directors (the "Board") with respect to certain issues relating to, among things, the Issuer's strategic decision-making and recent financial and operating performance. The Reporting Persons may also discuss the possibility of nominating a person to become a director of the Issuer.

The Reporting Persons intend to continuously review their investment in the Issuer and reserve the right to change their plans or intentions and to take any and all actions that the Reporting Persons may deem appropriate to maximize the value of their investment, including, among other things, acquiring additional securities of the Issuer, disposing of any securities of the Issuer owned by the Reporting Persons, or formulating other plans or proposals regarding the Issuer or its securities to the extent deemed advisable by the Reporting Persons. Any actions the Reporting Persons might undertake will be dependent upon the Reporting Persons' review of numerous factors, including, among other things, the price levels of the Common Stock, general market and economic conditions, ongoing evaluation of the Issuer's business, financial condition, operations and prospects, the relative attractiveness of alternative business and investment opportunities, the Reporting Persons' need for liquidity, and other future developments.

In addition, the Reporting Persons may, at any time and from time to time, (i) review or reconsider their position or change their purpose or formulate plans or proposals with respect thereto and (ii) consider or propose one or more of the actions described in subparagraphs (a) - (j) of Item 4 of Schedule 13D.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>As of the filing date of this Schedule 13D, SilverCape is the holder of record of 2,300,318 shares of Common Stock, representing approximately 11.1% of the shares of Common Stock currently issued and outstanding. Kennedy, as the managing director of SilverCape, has voting and investment power with respect to the Common Stock held by SilverCape. Kennedy disclaims any beneficial ownership of the Common Stock beneficially owned by SilverCape.</percentageOfClassSecurities>
        <numberOfShares>SilverCape has the sole voting and dispositive power over the shares of Common Stock held by it. Kennedy, as the managing director of SilverCape, has voting and investment power with respect to the Common Stock held by SilverCape. Kennedy disclaims any beneficial ownership of the Common Stock beneficially owned by SilverCape.</numberOfShares>
        <transactionDesc>Except as set forth above, there have been no transactions in the Common Stock by the Reporting Persons during the past 60 days.</transactionDesc>
        <listOfShareholders>No person other than the Reporting Persons is known by the Reporting Persons to have the right to receive dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by the Reporting Persons.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Except as otherwise described in this Schedule 13D and the Joint Filing Agreement attached hereto as Exhibit 1, (i) there are no contracts, arrangements, understandings, or relationships (legal or otherwise) among the persons named in Item 2 and between such persons and any person with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Exhibit 1Joint Filing Agreement, dated as of May 20, 2025.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>SilverCape Investments Limited</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Peter Kennedy</signature>
          <title>Managing Director</title>
          <date>05/20/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Peter Kennedy</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Peter Kennedy</signature>
          <title>Managing Director</title>
          <date>05/20/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>ex1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>JOINT
FILING AGREEMENT</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby agree as follows:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the parties named below agree to the joint filing
on their behalf of the statement on Schedule 13D (along with any amendments thereto) to which this joint filing agreement is attached
with respect to the Common Stock, $.001 par value per share, of Petmed Express, Inc., a Florida corporation, and further agree that this
joint filing agreement be included as Exhibit 1 to the Schedule 13D. In evidence thereof, the undersigned have duly executed this joint
filing agreement as of the date set forth below.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
May 20, 2025</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 215pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SilverCape
Investments Limited</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: -3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 215pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 215pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
<U>&#9;/s/ Peter Kennedy&#9;</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 215pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
Peter Kennedy</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 215pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
Managing Director &#9;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 215pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>/s/
Peter Kennedy&#9;&#9;</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 215pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
Peter Kennedy</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
